Status:
TERMINATED
Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer
Lead Sponsor:
Tata Memorial Hospital
Collaborating Sponsors:
Indian Council of Medical Research
Conditions:
Cancer of the Breast
Eligibility:
FEMALE
18-70 years
Phase:
PHASE2
Brief Summary
The advent of mammography and increased awareness of breast cancer has resulted in detection of smaller tumors, the majority of which would not have had metastasized to the axillary lymph nodes. The s...
Detailed Description
Axillary node dissection in operable breast cancer provides an accurate way of staging the disease. With increased popularity of screening and earlier diagnosis, most women do not harbor axillary meta...
Eligibility Criteria
Inclusion
- Clinically node negative operable breast cancer
- No prior incision or excision biopsy
Exclusion
- Palpable axillary lymph nodes
- Contraindications for injecting radiocolloid
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
478 Patients enrolled
Trial Details
Trial ID
NCT00128362
Start Date
September 1 2005
Last Update
June 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400 012